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Serologic analyses of antisera raised in mouse strain combinations differing at 
the major histocompatibility complex (H-2) indicate that each H.2 haplotype is 
characterized by numerous antigenic specificities. It has been proposed that the 
data are most easily explained in terms of two tightly linked loci, H-2K and H- 
2D (1-3). This "two-gene" model implies that the product of each H-2K or H-2D 
region bears several alloantigenic specificities. Antigenic specificities unique for 
a  single H-2K or H-2D region, or regions presumed to be of a common origin, 
have been designated "private" specificities, while antigenic specificities shared 
between different regions or different alleles of a region have been designated 
"public" specificities. The molecules determined by the H-2K and H-2D region 
are glycoproteins of an  apparent  mol wt  of 45,000  daltons.  Cullen et  al.  (4) 
analyzed the soluble H-2 molecules by coprecipitation with various antisera and 
demonstrated that, in the combinations tested, each H-2K or H-2D product bore 
private  and  public  specificities.  This  was  also  demonstrated by  lymphocyte 
redistribution studies in several strains (5, 6). After reviewing the data for and 
against the two-gene model, Klein noted that the great preponderance of data 
supported the model (7). Recently, however, co-capping (8) and immunoprecipi- 
tation techniques (9) have suggested that antisera to private and antisera to 
public specificities detect two separable molecules associated with the D region 
of the H-2  ~ haplotype. 
An additional approach to the question of the number of genes associated with 
the D d region recently became possible through the discovery of the BALB/c, H- 
2  loss mutant, designated BALB/c-H-2  ~°  (10). Skin from BALB/c was quickly 
rejected by the mutant (11-12 days), but grafts in the opposite direction survived 
indefinitely. No serological differences were detectable between wild type and 
mutant  with  the  notable  exception that  the mutant did  not  react with  one 
antiserum detecting public H-2 specificities (11). However another antiserum 
presumably of similar specificity reacted equally well with both strains.  Skin 
graft complementation studies localized the antigenic loss of the BALB/c-H-2  db 
mutant to the D end of its H-2 haplotype (11). Since the mutation occurred in an 
H-2  d  strain  and  since  recent precipitation  studies  from  this  laboratory  (9) 
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indicated that the D d region had two antigenically separable gene products, we 
have isolated the H-2 products of BALB/c-H-2 db and compared them to those of 
BALB/c. 
We report here that the H-2-associated mutant BALB/c-H-2  db is missing an 
antigenic specificity(ies) on an additional molecule chemically separable from 
the molecules bearing the private H-2 specificities. The gene determining this 
additional  molecule maps  within  or  close  to  the D  region  and  is  therefore 
genetically separable from the K, I, S, G, Qa-2, and Tla regions. The implica- 
tions  for  the  chromosomal fine  structure  and  two-gene model  of the  major 
histocompatibility complex are discussed. 
Materials and Methods 
Mice.  The BALB/c and BALB/c-H-2 db mice were of the subline Kh from the colony of H.  I. 
Kohn,  and the B6.K1 and B6.K2 mice were from the colony of L.  Flaherty.  Mice of strains A, 
A.AL,  B6-H-2  k, C3H, and C3H.OH were from the colony of D. H. Sachs. 
Alloantisera.  The immune sera and the strain combinations they were produced in are listed 
in Table I.  The anti-H-2.4(D4)  was produced by The Jackson Laboratory,  Bar Harbor,  Maine, 
under contract from the National Institute of Allergy and Infectious Diseases, and the other two 
reagents listed  in Table I  were produced  in this laboratory according to  previously  published 
methods (12). 
Absorptions of  Alloantisera.  In vivo absorptions were performed by injecting mice intraperito- 
neally with 0.5 ml of immune sera, waiting 2 h, and then bleeding from the oribital sinus. In vitro 
absorptions were carried out as outlined in the legend of Fig. 4. 
Cytotoxicity Assay.  Cytotoxic testing was done by the two-stage trypan blue assay as previ- 
ously described (13).  Selected newborn rabbit serum, diluted 1:5, was used as a  source of comple- 
ment. 
Chemical Analyses.  Radiolabeling, solubilization, precipitation, and sodium dodecyl sulfate- 
polyacrylamide  gel  electrophoresis  (SDS-PAGE) 1 were  all  performed  by  previously  described 
methods  (14).  Briefly,  spleen cells  (5  ×  107/ml) were  cultured  for  5  h  in  leucine-free Eagle's 
minimum  essential  medium  supplemented  with  glutamine  and  200  ~Ci/ml  3H-leucine  (New 
England Nuclear, Boston, Mass.). The radiolabeled cells were solubilized with 0.5% Nonidet Po40 
(Shell  Chemical  Company,  New  York)  in  0.01  M  Tris-0.15  M  NaC1,  pH  7.4.  The  lysate  was 
centrifuged at 100,000 g  for 1 h, after which the supernate was applied to a lentil lectin-Sepharose 
4B affinity column. The fraction eluted with 0.1 M alpha methyl mannoside was concentrated and 
stored at -70°C until use. 
Specific antigens were isolated by indirect precipitation. Radiolabeled antigen was incubated 
with  specific alloantisera,  after which  an excess  amount  of protein A-bearing Staphylococcus 
auerus  Cowan I  (SaCI) was added to precipitate antigen-antibody complexes.  The SaCI-precipi- 
rates were washed and the radiolabeled antigens were eluted with 2% SDS and 2% 2-mercaptoeth- 
anol. The eluates were analyzed on 10% polyacrylamide SDS gels. 
Results 
Sequential precipitations were performed to characterize the H-2 molecules 
associated with the wild-type BALB/c, and the mutant BALB/c-H-2  db in terms of 
their reactivity with antisera to public and private H-2 specificities. Antisera 
detecting K d and D ~ private specificities (H-2.31  and H-2.4, respectively)and an 
antiserum known to detect both K ~ and D d public specificities (H-2.6, 27, 28, 29) 
were used (Table I). These antisera were made in strain combinations such that 
1 Abbreviations used in this paper:  NMS,  normal mouse serum; SaCI, Staphylococcus aureus 
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TABLE  I 
Alloantisera  Used for Experiments 
Strain combination  Haplotypes involved  Specificity on BALB/c* 
(B10.AKM  ×  129)anti-B10.A* 
(B10 ×  A) anti-B10.D2 
C3H anti-C3H.SW 
(H-2"  × H-2  b) anti-H-2 a 
(H-2 b × H-2 a) anti-H-2 d 
H-2  k anti-H-2 ~ 
Private of D  region (H-2.4) 
Private of K  region  (H-2.31)  and 
Ia.ll  (weak) 
Public of K  and D  regions (H-2.6, 
27.28, 29) and Ia.8 
* The H-2 alloantigenic specificities present on BALB/c cells which can possibly be detected by 
each immune serum, as predicted by the H-2 chart. 
$ Produced by The Jackson Laboratory,  Bar Harbor,  Maine, under contract from the National 
Institute of Allergy and Infectious Diseases. 
when tested on H-2  d  strains the antisera to either of the private specificities 
would not contain antibodies to public specificities and vice versa, as predicted 
by the H-2 chart. 
For the initial  precipitation step antigen from BALB/c or the mutant was 
divided into two aliquots. One aliquot was pretreated with normal mouse serum 
(NMS) as a  control and the other aliquot was pretreated with a mixture of an 
excess amount of both the antiserum to the private K  region specificity and 
antiserum to the private D  region specificity. After incubation, precipitation 
was carried out with an excess amount of protein A-bearing SaCI. Both super- 
nates were then subdivided into three aliquots and tested for residual antigenic 
activity in  a  final  precipitation  step.  The  first  aliquot  was  tested  with the 
antiserum to the D  region private specificity, the second with the antiserum to 
the K  region private  specificity, and the third  with the antiserum detecting 
public specificities of both K  and D regions. The products of this final precipita- 
tion step were analyzed by SDS-PAGE. 
The  electrophoretic migration patterns  for the  sequential  precipitation  of 
wild-type antigen, BALB/c, are shown in Fig. 1. In the controls, the anti-H-2.4 
and anti-H-2.31 immune sera precipitated the expected H-2 molecules (panels 
no. 1 and 2, respectively), as did the antiserum to public specificities H-2.6, 27, 
28,  29  (panel no. 3).  The depletion of molecules bearing the private D  and K 
region specificities  (panels no.  4  and no.  5,  respectively) did not remove all 
molecules reactive with the antiserum to public specificities (panel no. 6). These 
results indicate that there is a  population of molecules which reacts with the 
antiserum  detecting public  H-2  specificities,  but  neither  of the  antisera  to 
private H-2  specificities. Therefore, these antisera defme three antigenically 
separable molecules associated with BALB/c, all of which have the same appar- 
ent tool wt (45,000 daltons) as determined by SDS migration patterns. 
Since BALB/c-H-2  db carries a loss mutation which apparently occurred in the 
H-2  complex,  it  was  of interest  to  determine  if the  three  above  described 
molecules associated with the H-2 haplotype of BALB/c were also detectable in 
the  mutant.  The  results  of the  co-precipitation  analysis  with  antigen  from 
BALB/c-H-2  db  are shown in Fig. 2. In the controls, in which antigen from the 
mutant was pretreated with NMS,  antibodies to the D  and K  region private 
specificities also precipitated the expected H-2 molecules (panels no. 1 and no. 2, 
respectively). However, with BALB/c-H-2  db antigen, complete removal of mole- HANSEN,  CULLEN,  MELVOLD~  KOHN,  FLAHERTY,  AND  SACHS 
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FIG.  1.  Electrophoretic  migration patterns  of BALB/c  antigen sequentially  precipitated 
with anti-H-2 immune sera (Table I). 3H-leucine-labeled antigen was pretreated by precipi- 
tation with the reagent or reagents  indicated on the left and the supernates from this first 
precipitation step were then tested for residual reactivity with the reagent indicated above 
the panels. The test precipitates were solubilized with SDS and subjected to disk electropho- 
resis on 10% polyacrylamide gels.  Using this system the H-2 molecules migrate to about 4 
cm, the Ia molecules  migrate between  5 and 7 cm, and a  nonspecific running front  (RF) 
appears at about 8 cm of gel. The top panels show that BALB/c antigens were precipitated 
by antisera to private (panels no.  1 and 2) and public (panel no. 3) specificities.  The lower 
three panels show that while pretreatment with antiserum to the private specificities H-2.4 
and 31 removed all molecules bearing the private specificities (panels no. 4 and 5, respec- 
tively),  the antiserum to public specificities still precipitated  some molecules of the same 
molecular weight (panel no. 6). Therefore,  there are three distinct classes of 45,000 tool wt 
molecules associated with BALB/c,  those that react with either of the private specificities 
(panels  no.  1 and 2)  and those  that  react  only with the  antiserum to public specificities 
(panel no.  6).  As indicated in Table I the antiserum to the private specificity H-2.31  also 
contains a low titer ofanti-Ia. 11 antibodies, resulting in the small poorly resolved Ia peak in 
panels no. 2 and 5. The antiserum to public specificities used in these gels contains anti-Ia.8 
antibodies,  resulting in the Ia peaks in panels no.  3 and 6. 
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cules bearing the private specificities caused concomitant removal of molecules 
detected by the antiserum to public specificities  (Fig.  2, panel no. 6). This is a 
strikingly different result than was seen with BALB/c  (compare panel no. 6 of 
Fig. 1 and Fig. 2). Therefore, in BALB/c a population of molecules (of45,000 mol 
wt)  was  detected  which  did  not  bear  either  of the  private  H-2  specificities, 
whereas in the mutant BALB/c-H-2 db there were no detectable molecules of this 
type. 
Genetic Mapping of the Antigenic Loss in the Mutant.  When the C3H (1-t-2  k) 
anti-C3H.SW  (H-2 b)  serum  was  absorbed  in  vivo  in  mutant  mice,  cytotoxic 
activity on cells from the mutant was removed, however some of the activity on 
the wild type, BALB/c, was retained. The retained antibodies were cytotoxic for 
greater than 80% of BALB/c spleen cells, a reaction like that seen with antibod- 
ies to H-2K and H-2D specificities.  Therefore, this absorbed antiserum appeared 
to be specific for an antigen(s) that was lost as a result of the mutation and by 
inference is specific for a  molecule that does not bear private H-2 specificities. 
To map the genetic locus coding for the antigen which is absent in the BALB/ 
c-H-2  db mutant, recombinant mouse strains were tested.  While BALB/c  (H-2  d) 
mice were positive with the C3H anti-C3H.SW serum absorbed in the mutant, 1554  MUTATION  IN  A  NEW  H-2-ASSOCIATED  HISTOCOMPATIBILITY  GENE 
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Fro.  2.  Electrophoretic migration patterns of BALB/c-H-2 db antigen sequentially precipi- 
tated with anti-H-2 immune sera (Table I). This experiment was carried out identically to 
the one shown in Fig. 1 except that antigen from the mutant strain rather than the strain of 
origin was used.  The top panels show that  BALB/c-H-2 db  antigens were precipitated by 
antiserum to private (panels no. 1 and 2) and antiserum to public (panel no. 3) specificities. 
The lower three panels show that pretreatment  with antisera to the private specificities 
(panels no. 4 and 5, respectively), concomitantly removed H-2 molecules precipitated by the 
antiserum to public specificities. Therefore only two classes of 45,000 tool wt molecules were 
detectable  with  antigen  from  the  mutant  BALB/c-H-2 db,  those  that  bear  either  of the 
private spjecificities (panels no. 1 and 2). The third class of 45,000 mol wt molecules found in 
BALB/c that reacted only with the antiserum to public specificities (Fig. 1, panel no. 6) was 
undetectable in the mutant  (Fig. 2, panel no. 6). 
,v 
2: 
C3H (H-2  k) mice were negative (as expected). Therefore the H-2~/H-2 k recombi- 
nants C3H.OH and A.AL were informative. As shown in Fig. 3, C3H.OH which 
is identical with the H-2  d haplotype except for its D region which came from H- 
2 k, did not react with absorbed antiserum. The strain A.AL which is identical 
with the H-2 k haplotype except for its D region, which came from  H-2  d, did react 
with this absorbed antiserum. Therefore both of these recombinants map the 
antigenic loss of the mutant in or to the right of the D region. 
The C3H and C3H.SW, like most congenic strains differ not only by H-2 genes 
but also by genes closely linked to H-2.  Recently the Qa-1 (15) and Qa-2  (16) 
regions have been defined by antigens which map to the right of H-2 between 
the D  and Tla regions. To map the antigenic loss of the BALB/c-H-2  db mutant 
relative to these other loci the B6.K1 and B6.K2 recombinants were tested. To 
assure that only the relevant antigen was being assayed, the C3H anti-C3H.SW 
serum absorbed in the mutant was then absorbed in vitro with cells from B6, 
B6~/-2  k, B6.K1,  and B6.K2 and tested for residual cytotoxicity against BALB/c 
cells.  As  shown  in  Fig.  4  the  B6.K1-  and  B6.K2-recombinant strains  have 
segments of chromosome from B6, A, and B6~/-2  k. Cells from strains B6 and A 
reacted with the antiserum absorbed in the mutant, while cells from B6,~/-2  k did 
not. The B6.K1 and B6.K2 strains both derived their Tla region from B6I-/-2 k, a 
strain that typed negative with the absorbed antiserum and yet both the B6.K1 
and B6.K2  strains typed positive. This result maps the antigenic loss in the 
BALB/c-H-2  '~° mutant to the left of the Tla region. Differences in a serologically 
detected antigen, Qa-2, as well as a minor histocompatibility antigen, have been 
demonstrated between the B6K1 and B6.K2  strains  (16). The Qa-2  region of HANSEN,  CULLEN,  MELVOLD,  KOHN,  FLAHERTY,  AND  SACHS  1555 
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FIG.  3.  Genetic mapping of the antigenic loss of the BALB/c-H-2  ~  mutant using intra-H- 
2-recombinant mouse strains. BALB/c mice have the H-2  ~ haplotype and C3H mice have the 
H-2 k haplotype. Both the C3H.OH and A.AL strains arose from recombination between the 
1-1-2 k  haplotype of C3H and the 1I-2 ~ haplotype of DBA/2. The antiserum absorbed in the 
mutant mice was cytotoxic for greater than 80% of spleen cells with a titer of 1:16 on strains 
BALB/c and A.AL. 1~o lysis above background (less than 10%) was seen at a 1:2 dilution on 
spleen cells from C3H, C3H.OH, and BALB/c-H-2  d~. 
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FIG.  4.  Genetic mapping of the antigenic loss of the BALB/c-H-2 db mutant using recombi- 
nant strains resulting from cross-overs to the right of H-2.  The  strains were tested for the 
ability to remove the activity on BALB/c cells of  the antiserum absorbed in the mutant. 5 × 
l0  t lymph node and spleen cells were incubated with 0.05 ml of the antiserum absorbed in 
the mutant for 1 h on ice after which cells were removed and the residual cytotoxic titer on 
BALB/c spleen cells was  determined. Cells from strains B6,  A,  B6.K1,  and  B6.K2  all 
completely removed reactivity on BALB/c cells of the antiserum absorbed in the mutant, 
indicating a shared antigen. Cells from strain B6-H-2 k did not remove reactivity on BALB/c 
(titer 1:8), indicating a lack of the shared antigen. 
B6.K1  came from B6J-/-2 k,  a  strain  that  was  negative with the  antiserum 
absorbed in the mutant and yet B6.K1  was positive.  Therefore the  antigen 
present in BALB/c and not the mutant BALB/c-H-2  db is not Qa-2 and maps to 
the left of the Qa-2 region. Because the A and B6 strains both reacted with the 
antiserum absorbed in the mutant, mapping studies using the B6.K1 and B6.K2 
strains cannot genetically map the antigenic loss in the mutant relative to the 
Qa-1 region. Therefore, combining the results of Figs. 3 and 4, the antigenic loss 
in BALB/c-H-2  ~b can be mapped into the D-Qa-1 interval. 
Discussion 
The data presented here compare the H-2 molecules of BALB/c and its co- 
isogenic mutant,  BALB/c-H-2  db.  Sequential precipitation experiments using 
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populations of H-2  molecules associated with BALB/c.  Two of the classes of 
molecules are characterized by their reactivity with antisera to either K  or D 
region private specificities and also antisera to public specificities. These by 
definition are the classical transplantation antigens, the products of the H-2K 
and H-2D  regions.  A  third  class  of molecules does not bear either private 
specificity but reacts with an antiserum to public specificities. As determined  by 
migration in SDS-PAGE all three populations of H-2 molecules have the same 
apparent mol wt of 45,000 daltons.  These results  are consistent with those 
reported previously which demonstrated two separable products associated with 
the D end of the H-2 d haplotype using co-capping on the lymphocyte  membrane 
(8) and by immunochemical techniques (9). 
Sequential precipitations with antigen from the mutant, BALB/c-H-2  db, indi- 
cated the presence of only two classes of H-2 molecules, those bearing either the 
H-2K or H-2D private specificity. The third class of molecules found in BALB/c 
which did not bear private  specificities but  did react with the antiserum to 
public specificities, was undetectable in the mutant. This result indicates that 
there is an antigen which is expressed in the wild-type strain, BALB/c, but not 
in the mutant, BALB/c-H-2 'tb, and that this antigen is carried on a molecule 
distinct from the classical transplantation antigens K and D. 
Antibodies specific for the molecule undetectable in the mutant were produced 
by in vivo absorption of the antiserum to public specificities with mutant cells. 
By inference, these antibodies are specific for alloantigens on the third class of 
45,000 mol wt molecules found in the strain of origin but not in the mutant. 
Using  the  antiserum  absorbed  in  the  mutant  and  intra-H-2-recombinant 
strains, the antigenic loss in the mutant was genetically mapped in or to the 
right of the D region. Recently derived B6-recombinant strains have been used 
to define the Qa-1 (15) and Qa-2  (16) regions to the right of the H-2  complex, 
between the D and Tla regions. Using the B6-recombinant strains the antigenic 
loss in the H-2  db mutant was mapped to the left of the Tla and Qa-2  regions. 
Therefore, the antigen detected in BALB/c but not the mutant is coded for by a 
gene in the D-Qa-1  interval.  Our results confirm and extend the skin graft 
complementation studies of McKenzie et al.  which mapped the mutation of 
BALB/c-H-2 db  into  or to  the right of the D  region  (11). This  agreement in 
mapping also makes it more likely that the antigenic loss in the mutant detected 
serologically is  on the same molecule as  the histocompatibility antigen loss 
detected by skin grafting. 
We tentatively designate the molecule detected in the strain of origin, BALB/ 
c and not the mutant BALB/c.H-2  do as D'. This nomenclature is used because no 
recombinants have been found that separate D'  from the D  region product 
carrying the private specificity, and D' is detectable serologically and by immu- 
noprecipitation with conventional anti-H-2 antisera. 
There are some data supporting the contention that D' is a histocompatibility 
antigen similar to the H-2K and H-2D antigens. Like K and D, D' is a molecule 
of an apparent mol wt of 45,000 daltons.  Its affinity for lentil lectin and its 
detection by  incorporation of 3H-leucine  indicate that  D'  is  a  glycoprotein. 
Antibodies specific for D'  were found to be cytotoxic for greater than 80% of 
spleen cells, a reaction characteristic of antibodies to K and D and not antibodies 
to other H-2-associated antigens such as Ia, Ss, G, or TL. It seems likely that the HANSEN,  CULLEN~ MELVOLD, KOHN,  FLAHERTY,  AND  SACHS  1557 
mutation accounting for the rapid skin graft rejection involves the D' molecule 
indicating that it is  a  strong histocompatibility antigen.  Of course a  second 
mutation or deletion of multiple genes might also explain the data. 
Presumably D' is less polymorphic than the K and D antigens because it was 
not previously recognized by the strain distribution patterns of  H-2 alloantigenic 
specificities and D' has only been detected because it bears a shared alloanti- 
genic specificity(ies) but lacks a haplotype-specific alloantigen. Since the genes 
coding for D  and D'  are tightly linked, antisera produced to detect D  region 
specificities could contain antibodies specific for determinants on D and/or D'. It 
is therefore unclear which molecule, D or D', or both, bear the public specifici- 
ties currently assigned to the D region. Further serologic and immunochemical 
studies  utilizing the  BALB/c-H-2  db  mutant should help  in  determining the 
molecular basis of the D-end specificities. However, recombinants that separate 
D  from D'  will be required for accurate assignment of specificities to these 
molecules. If D'  antigens were found to be cross-reactive with either K  or D 
alloantigens, i.e.  shared public specificities between D'  and K  or D,  then a 
structural homology could be implied. Also since considerable chemical homolo- 
gies have been demonstrated between the partial amino acid sequences of the 
products of H-2K and H-2D  (17-19)  it would be informative to sequence D'. 
Serological and chemical studies are in progress to determine whether D' has 
structural homologies with D and/or K. 
The present data with the BALB/c-H-2  db mutant suggest that the currently 
accepted two-gene model for the mouse major histocompatibility complex must 
be  extended at  least  in  certain haplotypes to  a  "three-gene" model perhaps 
homologous to the HLA-A, B, and C loci of man (20). Furthermore, the molecu- 
lar  similarities  of the  products determined by  genes mapping between and 
includingH-2 and Tla may indicate multiple duplications of genetic information 
on this chromosomal segment. 
Summary 
Sequential precipitations of soluble BALB/c antigen with antisera detecting 
private and public H-2 specificities indicated three distinct classes of molecules 
of 45,000 mol wt. However, only two of  these classes of  molecules were detectable 
in antigen from the loss mutant, BALB/c-H-2  db. The class of molecules, detecta- 
ble in the wild-type strain but missing in the mutant, does not bear private 
specificities but does react with an antiserum detecting H-2 public specificities. 
Absorption in mutant mice of the antiserum to public specificities, left antibod- 
ies specific for the antigen detectable in BALB/c but not BALB/c-H-2  ~b. Genetic 
mapping studies using this specific antiserum indicated that the antigenic loss 
of this mutant is in a gene which maps in or close to the H-2D region, separable 
from the H-2K, S, G, Qa-2,  and Tla regions. 
Received for publication 26 January 1977. 
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